Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2012
03/06/2012US8129541 5-phenylthiazole derivatives and use as PI3 kinase inhibitors
03/06/2012US8129537 Compounds as PDE IV and TNF inhibitors
03/06/2012US8129418 Macrocyclic compounds and methods of treatment
03/06/2012US8129407 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/06/2012US8129381 Caspase inhibitors and uses thereof
03/06/2012US8129380 Phthalazinone derivatives
03/06/2012US8129379 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/06/2012US8129378 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
03/06/2012US8129373 Carbonyl compounds
03/06/2012US8129371 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors
03/06/2012US8129351 for treatment of atopic conditions (dermatitis, allergies) and influenza virus; point mutations
03/06/2012US8129332 Reagents and methods for smooth muscle therapies
03/06/2012US8129331 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT
03/06/2012US8129167 UL16 binding protein 4
03/06/2012US8129144 Papilloma pseudovirus and preparation
03/06/2012US8129112 Polymorphisms in the human CYP2D6 gene promoter region and their use in diagnostic and therapeutic applications
03/06/2012US8128906 Stabilized uncoated particles of reversed liquid crystalline phase materials
03/06/2012CA2525383C Use of heterocyclic compounds as scce inhibitors
03/06/2012CA2506617C Colon cancer metastasis inhibitor
03/06/2012CA2483707C Microparticles bearing cells and active substances
03/06/2012CA2480666C Tnp-470 polymer conjugates and use thereof
03/06/2012CA2476056C Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
03/06/2012CA2434831C Polypeptide drug substances
03/06/2012CA2370697C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
03/06/2012CA2348998C Lipoic acid derivatives and their use in treatment of disease
03/01/2012WO2012027696A1 Alumina nanoparticle bioconjugates and methods of stimulating an immune response using said bioconjugates
03/01/2012WO2012027495A1 Piperazinylpyrimidine analogues as protein kinase inhibitors
03/01/2012WO2012027482A2 Compounds, compositions and methods related to ppar antagonists
03/01/2012WO2012027462A2 Compositions and methods for treating neoplasia
03/01/2012WO2012027445A1 Methods of administering an egfr inhibitor
03/01/2012WO2012027379A2 Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
03/01/2012WO2012027328A2 Anti-ox40 antibodies and methods of using the same
03/01/2012WO2012027324A2 Treatment for neoplastic diseases
03/01/2012WO2012027322A1 Oxadiazole inhibitors of leukotriene production
03/01/2012WO2012027274A2 Compositions and methods for imaging
03/01/2012WO2012027204A1 End-capped polymers
03/01/2012WO2012026663A1 Anticancer supplement including undecylenic acid, conjugated linoleic acid, and/or a conjugated linoleic acid isomer
03/01/2012WO2012026614A1 Composition suppressing matrix-metalloproteinase activity
03/01/2012WO2012026511A1 Pharmaceutical composition
03/01/2012WO2012026495A1 Novel hydantoin derivative and medicinal agent comprising same as active ingredient
03/01/2012WO2012026434A1 Crystal of tricyclic pyrazolopyrimidine derivative
03/01/2012WO2012026433A1 Free crystal of tricyclic pyrazolopyrimidine derivative
03/01/2012WO2012025762A2 Pure intermediate
03/01/2012WO2012025054A1 Diimidated derivative of berbamine, and preparation method therefor and use thereof
03/01/2012WO2012024893A1 Certain chemical entities, compositions, and methods
03/01/2012WO2012024818A1 Novel anphthoquinones for disease therapies
03/01/2012WO2012000103A8 Methods of targeting pten mutant diseases and compositions therefor
03/01/2012WO2011156617A3 Anti-egfr antibodies
03/01/2012WO2011143423A3 Compounds useful as inhibitors of atr kinase
03/01/2012WO2011142618A3 Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased
03/01/2012WO2011141716A3 Modulators of chk-1 activity
03/01/2012WO2011122916A9 Composition for increasing trail sensitivity, containing an inhibitor for inhibiting the expression or activity of tip41 which is a trail sensitizer target gene
03/01/2012WO2011119628A3 Compositions and methods for self-adjuvanting vaccines against microbes and tumors
03/01/2012WO2011109334A3 Localization of agents at a target site with a composition and an energy source
03/01/2012US20120053559 Treatment of Proliferative Diseases with Epothilone Derivatives and Radiation
03/01/2012US20120053253 Gene signatures for cancer prognosis
03/01/2012US20120053244 Alkylamido Compounds and Uses Thereof
03/01/2012US20120053242 Compositions rich in omega-3 fatty acids with a low content in phytanic acid
03/01/2012US20120053235 Dihydromyricetin as an IKK-beta inhibitor used for treatment of arthritis, cancer and autoimmune conditions, and other diseases or disorders
03/01/2012US20120053232 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 4 (TSSC4)
03/01/2012US20120053228 Splice-region antisense composition and method
03/01/2012US20120053226 Design of oligonucleotide analogs as therapeutic agents
03/01/2012US20120053225 Akt tyrosine 176 phosphorylation cancer biomarker
03/01/2012US20120053224 Compositions and methods for micro-rna expression profiling of cancer stem cells
03/01/2012US20120053219 Processes of making and using pharmaceutical formulations of antineoplastic agents
03/01/2012US20120053214 The little molecule compound which used for promoting the stem cells hyperplasia and the use thereof
03/01/2012US20120053211 Treatment of pancreatic cancer
03/01/2012US20120053209 Anticancer compounds, preparation thereof, and therapeutic use thereof
03/01/2012US20120053208 Curcumin Analogs as Dual JAK2/STAT3 Inhibitors and Methods of Making and Using the Same
03/01/2012US20120053202 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
03/01/2012US20120053201 Substituted hydroxamic acids and uses thereof
03/01/2012US20120053196 Combination Treatment of Breast Cancer
03/01/2012US20120053195 Hydrobromide salts of a pyrazolylaminoquinazoline
03/01/2012US20120053194 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
03/01/2012US20120053193 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
03/01/2012US20120053192 Heterocyclic Substituted Acardite Derivate and Application Thereof
03/01/2012US20120053188 Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
03/01/2012US20120053186 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
03/01/2012US20120053185 Method to treat melanoma in braf inhibitor-resistant subjects
03/01/2012US20120053184 Salts of 3-(1h-ind0l-3-yl)-4-[2-(4-methyl-piperazin-i-yl)-quinazolin-4-yl]-pyrrole-2, 5-di one
03/01/2012US20120053183 Piperazinylpyrimidine analogues as protein kinase inhibitors
03/01/2012US20120053179 Rho-Kinase Inhibitors
03/01/2012US20120053178 3-(1,2,3-Triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives
03/01/2012US20120053177 Compounds and methods for kinase modulation, and indications therefor
03/01/2012US20120053174 Quinazoline compounds and methods of use thereof
03/01/2012US20120053170 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs
03/01/2012US20120053167 Triazine Derivatives as Kinase Inhibitors
03/01/2012US20120053166 4-Oxadiazol-2-YL-Indazoles as Inhibitors of P13 Kinases
03/01/2012US20120053162 Certain chemical entities, compositions, and methods
03/01/2012US20120053159 Isotopologues of lenalidomide
03/01/2012US20120053147 Thiazolopyrimidinone derivatives as pi3 kinase inhibitors
03/01/2012US20120053144 Cobalamin Taxane Bioconjugates For Treating Eye Disease
03/01/2012US20120053136 Diagnosis and treatment of drug-resistant ewing`s sarcoma
03/01/2012US20120053129 Target-activated cell/tissue-penetrating peptide for delivery of impermeable compounds and use thereof
03/01/2012US20120053128 Method of inhibiting angiogenesis
03/01/2012US20120053113 MANUFACTURE OF INTER-ALPHA-INHIBITOR (IaIp) FROM PLASMA
03/01/2012US20120052292 Novel medical device coatings
03/01/2012US20120052142 BIOLOGICALLY ACTIVE COMPOSITIONS FROM Schisandra chinensis FOR TREATING COLORECTAL CANCER
03/01/2012US20120052132 Compositions and methods for treatment of body weight conditions
03/01/2012US20120052116 Immunogenic epitopes of ngep antigen
1 ... 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 ... 2211